Javascript must be enabled to continue!
Towards Understanding the Drivers of Antibody-Antigen Binding
View through CrossRef
Abstract
Antibody therapeutics are capable of binding to target antigens with a high degree of specificity and affinity. Gaining an understanding of how antibody–antigen interactions are governed can provide valuable insights that may assist with rational paratope design and epitope prediction. In this work, we apply the FTMap algorithm to systematically characterize binding hot spots – regions on a protein surface that contribute disproportionately to molecular recognition, to a set of 50 antibody–antigen complexes. From our analysis, we find that interface hot spots are typically concentrated on the paratope (antibody side) of the interface, indicating that paratopes typically function as hot spot rich environments in which the antigen can bind.
Additionally, we observe that hot spot formation on both sides of the interface is particularly enriched by Trp and Tyr residues, underscoring the key role of aromatic side chains with some amphiphilic character in antibody design. Furthermore, we find that when strong interface hot spots are detected, they tend to persist in the apo conformation, suggesting that there is an inherent structural stability that surrounds core interface hot spots. These findings demonstrate the utility of computational solvent mapping for analyzing protein-protein interfaces, and highlights that at least in most cases antibodies drive antibody-antigen interactions.
Statement of Significance
Antibodies represent an important and expanding class of therapeutics for a range of diseases including infectious diseases, cancers, and autoimmune disorders. Enhancing our fundamental understanding of what drives antibody-antigen interactions is critical to our enhancing our ability to modulate these interactions. This work presents a systematic, physics-based study of antibody-antigen interfaces, and identifies key drivers of binding.
Title: Towards Understanding the Drivers of Antibody-Antigen Binding
Description:
Abstract
Antibody therapeutics are capable of binding to target antigens with a high degree of specificity and affinity.
Gaining an understanding of how antibody–antigen interactions are governed can provide valuable insights that may assist with rational paratope design and epitope prediction.
In this work, we apply the FTMap algorithm to systematically characterize binding hot spots – regions on a protein surface that contribute disproportionately to molecular recognition, to a set of 50 antibody–antigen complexes.
From our analysis, we find that interface hot spots are typically concentrated on the paratope (antibody side) of the interface, indicating that paratopes typically function as hot spot rich environments in which the antigen can bind.
Additionally, we observe that hot spot formation on both sides of the interface is particularly enriched by Trp and Tyr residues, underscoring the key role of aromatic side chains with some amphiphilic character in antibody design.
Furthermore, we find that when strong interface hot spots are detected, they tend to persist in the apo conformation, suggesting that there is an inherent structural stability that surrounds core interface hot spots.
These findings demonstrate the utility of computational solvent mapping for analyzing protein-protein interfaces, and highlights that at least in most cases antibodies drive antibody-antigen interactions.
Statement of Significance
Antibodies represent an important and expanding class of therapeutics for a range of diseases including infectious diseases, cancers, and autoimmune disorders.
Enhancing our fundamental understanding of what drives antibody-antigen interactions is critical to our enhancing our ability to modulate these interactions.
This work presents a systematic, physics-based study of antibody-antigen interfaces, and identifies key drivers of binding.
Related Results
Deep Geometric Framework to Predict Antibody-Antigen Binding Affinity
Deep Geometric Framework to Predict Antibody-Antigen Binding Affinity
In drug development, the efficacy of an antibody depends on how the antibody interacts with the target antigen. The strength of these interactions gives an indication of how succes...
Mesoscale Modeling of a Nucleosome-Binding Antibody (PL2-6): Mono- vs. Bivalent Chromatin Complexes
Mesoscale Modeling of a Nucleosome-Binding Antibody (PL2-6): Mono- vs. Bivalent Chromatin Complexes
ABSTRACT
Visualizing chromatin adjacent to the nuclear envelope (denoted “epichromatin”) by
in vitro
immunost...
Immune-induced antibody-DNA hybrid condensates
Immune-induced antibody-DNA hybrid condensates
We report here the combined use of Watson-Crick and antibody-antigen interactions to induce phase separation of DNA-antibody hybrid condensates. To achieve this, we have used an an...
Correlation of N-glycan dynamics and interaction network with allosteric antigen binding and Fc receptor recognition
Correlation of N-glycan dynamics and interaction network with allosteric antigen binding and Fc receptor recognition
Aim: Fragment crystallizable (Fc) glycans modulate Fc conformations and functions, and glycan may also regulate antigen recognition. In the antibody drug development, glycosylation...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131
A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131
Abstract
The increase of antimicrobial resistance (AMR), and lack of new classes of licensed antimicrobials, have made alternative treatment ...

